Gimv sells its stake in Human Inference, one of the European leaders in Data Quality
Gimv sells its stake in Human Inference to Neopost (www.neopost.com), the European leader and number two worldwide supplier of mailroom solutions. Neopost, listed on Euronext Paris (ticker: NEO), has a direct presence in 29 countries, with 5.900 employees and annual sales of EUR 1.003 million in 2011. Its products and services are sold in more than 90 countries.
Human Inference (www.humaninference.com), founded in 1986 and headquartered in Arnhem (the Netherlands), is one of the leading European data quality solution providers. In recent years Human Inference transitioned from delivering data quality solutions to a provider of master data management solutions for customer databases. Pooling all the information concerning a customer into a single master database drives a significant improvement in sales and marketing, operational efficiency and risk management. The systems developed by Human Inference can be used in all languages and adapted to all cultures. This enables organizations to interact with their customers in a more relevant and personal way. Human Inference supports major banks, insurance companies and other large businesses across Europe. Amongst their tier one clients are ABN AMRO, Center Parcs, E-ON, ING Bank and Nutricia.
Winfried van Holland, CEO of Human Inference said: “In past years Gimv as lead investor supported Human Inference in staying a visionary data quality vendor and evolve into one of the internationally recognized players in the field of Master Data Management. Our customers have supported this vision and we would like to thank them for this.”
The sale of Human Inference has had a positive impact of EUR 5.2 million (EUR 0.22 per share) on Gimv's most recently published equity value as at 30 September 2012. Over the entire period, this represents an investment with a return that is in line with Gimv’s long-term average. No further financial details will be published about this transaction.